Femme et Homme
- | Pays :
- Spain
- Germany
- United States
- Les 4 autres...
- | Organes : -
- | Spécialités : -
Extrait
The purpose of this study is to compare the safety, tolerability and antiviral activity between once-daily (QD) and twice-daily (BID) dosing of lopinavir/ritonavir and to further characterize the pharmacokinetics of once-daily dosing of lopinavir/ritonavir.
Critère d'inclusion
- HIV Infections